Vaxart, Inc. – NASDAQ:VXRT

Vaxart stock price today

$0.355
-0.37
-51.42%
Financial Health
0
1
2
3
4
5
6
7
8
9

Vaxart stock price monthly change

+9.06%
month

Vaxart stock price quarterly change

+9.06%
quarter

Vaxart stock price yearly change

+21.83%
year

Vaxart key metrics

Market Cap
133.48M
Enterprise value
53.43M
P/E
-0.73
EV/Sales
278.32
EV/EBITDA
-0.35
Price/Sales
404.93
Price/Book
0.70
PEG ratio
0.01
EPS
-0.52
Revenue
7.23M
EBITDA
-73.93M
Income
-81.74M
Revenue Q/Q
223.11%
Revenue Y/Y
937.30%
Profit margin
-84525.52%
Oper. margin
-28136.98%
Gross margin
0%
EBIT margin
-28136.98%
EBITDA margin
-1022.61%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Vaxart stock price history

Vaxart stock forecast

Vaxart financial statements

Vaxart, Inc. (NASDAQ:VXRT): Profit margin
Jun 2023 1.35M -22.55M -1660.53%
Sep 2023 446K -17.4M -3901.35%
Dec 2023 3.24M -17.37M -535.44%
Mar 2024 2.18M -24.41M -1119.53%
Vaxart, Inc. (NASDAQ:VXRT): Analyst Estimates
Dec 2023 3.24M -17.37M -535.44%
Mar 2024 2.18M -24.41M -1119.53%
Oct 2025 200K -20.25M -10128.67%
Dec 2025 400K -20.25M -5064.33%
  • Analysts Price target

  • Financials & Ratios estimates

Vaxart, Inc. (NASDAQ:VXRT): Debt to assets
Jun 2023 122653000 37.58M 30.64%
Sep 2023 105642000 34.12M 32.3%
Dec 2023 91830000 34.02M 37.05%
Mar 2024 88670000 32.97M 37.19%
Vaxart, Inc. (NASDAQ:VXRT): Cash Flow
Jun 2023 -17.47M -1.58M 13.89M
Sep 2023 -15.00M 4.97M -8K
Dec 2023 -13.52M 15.10M -66K
Mar 2024 -21.19M -5.02M 18.19M

Vaxart alternative data

Vaxart, Inc. (NASDAQ:VXRT): Employee count
Aug 2023 164
Sep 2023 164
Oct 2023 164
Nov 2023 164
Dec 2023 164
Jan 2024 164
Feb 2024 164
Mar 2024 109
Apr 2024 109
May 2024 109
Jun 2024 109
Jul 2024 109

Vaxart other data

100.00% 0.00%
of VXRT is owned by hedge funds
12.73M -31.58M
shares is hold by hedge funds

Vaxart, Inc. (NASDAQ:VXRT): Insider trades (number of shares)
Period Buy Sel
Jun 2024 20000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
WATSON W. MARK director
Common Stock 20,000 $0.68 $13,580
Purchase
WATSON W. MARK director
Common Stock 20,000 $0.76 $15,140
Option
YEDID ROBERT A. director
Common Stock 8,000 $2.39 $19,120
Option
YEDID ROBERT A. director
Common Stock 18,240 $0.31 $5,654
Option
YEDID ROBERT A. director
Stock Option (right to buy) 8,000 $2.39 $19,120
Option
YEDID ROBERT A. director
Stock Option (right to buy) 18,240 $0.31 $5,654
Purchase
AHMAD FUAD officer: Interim .. Common Stock 5,000 $3.22 $16,100
Option
TUCKER SEAN officer: SVP, Chi.. Stock Option (right to buy) 40,000 $0.77 $30,800
Option
TUCKER SEAN officer: SVP, Chi.. Common Stock 40,000 $0.77 $30,800
Option
ECHERD MARGARET officer: SVP, Pri.. Stock Option (right to buy) 666 $5.17 $3,443
Insider Compensation
Mr. Cezar Andrei Floroiu M.B.A. (1973) Chief Executive Officer, Pres, Principal Financial Officer & Director
$538,150
Dr. Sean N. Tucker (1968) Senior Vice President & Chief Scientific Officer $530,720
Ms. Margaret A. Echerd (1959) Senior Vice President & Principal Accounting Officer $523,070
Monday, 2 December 2024
globenewswire.com
Wednesday, 13 November 2024
zacks.com
seekingalpha.com
globenewswire.com
Monday, 30 September 2024
globenewswire.com
Friday, 30 August 2024
globenewswire.com
Thursday, 15 August 2024
benzinga.com
Thursday, 8 August 2024
seekingalpha.com
zacks.com
globenewswire.com
Friday, 2 August 2024
globenewswire.com
Thursday, 27 June 2024
seekingalpha.com
Monday, 17 June 2024
globenewswire.com
Thursday, 13 June 2024
globenewswire.com
globenewswire.com
Thursday, 23 May 2024
globenewswire.com
Monday, 13 May 2024
Seeking Alpha
Wednesday, 27 March 2024
GlobeNewsWire
Thursday, 7 March 2024
GlobeNewsWire
Monday, 26 February 2024
Zacks Investment Research
Friday, 23 February 2024
Zacks Investment Research
Tuesday, 20 February 2024
Zacks Investment Research
Thursday, 2 November 2023
Seeking Alpha
Wednesday, 11 October 2023
GlobeNewsWire
Tuesday, 12 September 2023
InvestorPlace
Tuesday, 15 August 2023
Zacks Investment Research
Thursday, 3 August 2023
Seeking Alpha
Zacks Investment Research
Wednesday, 7 June 2023
InvestorPlace
Monday, 24 April 2023
The Motley Fool
  • What's the price of Vaxart stock today?

    One share of Vaxart stock can currently be purchased for approximately $0.36.

  • When is Vaxart's next earnings date?

    Unfortunately, Vaxart's (VXRT) next earnings date is currently unknown.

  • Does Vaxart pay dividends?

    No, Vaxart does not pay dividends.

  • How much money does Vaxart make?

    Vaxart has a market capitalization of 133.48M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6796.26% to 7.38M US dollars.

  • What is Vaxart's stock symbol?

    Vaxart, Inc. is traded on the NASDAQ under the ticker symbol "VXRT".

  • What is Vaxart's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Vaxart?

    Shares of Vaxart can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Vaxart's key executives?

    Vaxart's management team includes the following people:

    • Mr. Cezar Andrei Floroiu M.B.A. Chief Executive Officer, Pres, Principal Financial Officer & Director(age: 52, pay: $538,150)
    • Dr. Sean N. Tucker Senior Vice President & Chief Scientific Officer(age: 57, pay: $530,720)
    • Ms. Margaret A. Echerd Senior Vice President & Principal Accounting Officer(age: 66, pay: $523,070)
  • How many employees does Vaxart have?

    As Jul 2024, Vaxart employs 109 workers.

  • When Vaxart went public?

    Vaxart, Inc. is publicly traded company for more then 43 years since IPO on 11 Dec 1981.

  • What is Vaxart's official website?

    The official website for Vaxart is vaxart.com.

  • Where are Vaxart's headquarters?

    Vaxart is headquartered at 170 Harbor Way, South San Francisco, CA.

  • How can i contact Vaxart?

    Vaxart's mailing address is 170 Harbor Way, South San Francisco, CA and company can be reached via phone at +65 05503500.

Vaxart company profile:

Vaxart, Inc.

vaxart.com
Exchange:

NASDAQ

Full time employees:

109

Industry:

Biotechnology

Sector:

Healthcare

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.

170 Harbor Way
South San Francisco, CA 94080

CIK: 0000072444
ISIN: US92243A2006
CUSIP: 92243A200